Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
What is your approach to biologic therapy in older adults (80+) and CKD with RA?
Related Questions
Do you feel comfortable using Jak inhibitors in patients with a strong family history of CAD, but no other risk factors?
Would you continue Jak inhibitor therapy in a patient with long standing, previously refractory RA in their 60s who was found to have stenosis of the left common femoral artery and no other history of arteriosclerotic disease?
Would you escalate therapy in a patient with rheumatoid arthritis without synovitis, but a new rheumatoid nodule?
How do you approach managing nausea and GI side effects when initiating methotrexate?
How do you approach restarting cDMARDS/bDMARDS in a patient with active RA after incidence of disseminated CNS VZV infection while on tofacitinib?
When do you recommend initiation of targeted therapies in active RA with history of malignancy?
Do you use the peri-operative management of biologics and DMARDs guidelines, which were mainly based on total hip and knee replacement surgeries, for all peri-operative surgical management?
Can you use leflunomide and rituximab in a patient with both multiple sclerosis and rheumatoid arthritis?
How do you counsel patients with RA stable on csDMARDs on whether to attempt tapering or not?
How do you help patients understand the difference between prolonged morning stiffness and pain?
